Joseph C.F. Scheeren's most recent trade in Barinthus Biotherapeutics Plc. - ADR was a trade of 19,516 Share Option (Right to Buy) done . Disclosure was reported to the exchange on May 10, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Barinthus Biotherapeutics ... | Joseph C.F. Scheeren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 19,516 | 19,516 | - | - | Share Option (Right to Buy) |